PARP inhibitors resistance: mechanisms and perspectives

E Giudice, M Gentile, V Salutari, C Ricci, L Musacchio… - Cancers, 2022 - mdpi.com
… PARPis resistance. This review aims to analyze the mechanisms underlying PARPis resistance
… potential therapeutic strategies to overcome these processes of resistance in the future. …

Mechanisms of action for different checkpoint inhibitors

P Berraondo - HemaSphere, 2019 - journals.lww.com
… In addition to the induction of expression through this adaptive mechanism of resistance,
ligands can be intrinsically expressed due to genetic rearrangements in the tumor cell. This is …

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

SL Topalian, JM Taube, RA Anders… - Nature Reviews Cancer, 2016 - nature.com
… system; therefore, biomarkers of response and resistance to anti-CTLA4 therapy may differ
from other immune checkpoint inhibitors that have different mechanisms of action (MOAs) 15 . …

[HTML][HTML] Mechanisms of immune-related complications in cancer patients treated with immune checkpoint inhibitors

D König, H Läubli - Pharmacology, 2021 - karger.com
… complication of treatment with checkpoint inhibitors. While the clinical … exact mechanisms
of irAEs are not well understood [14, 15]. In this review, the current knowledge of mechanisms

Translational biomarkers and rationale strategies to overcome resistance to immune checkpoint inhibitors in solid tumors

JA Chen, W Ma, J Yuan, T Li - Tumor Microenvironment, 2020 - Springer
… or progress and become immunotherapy-resistant tumors [14]. Impaired MHC class I antigen
processing has been proposed as a mechanism of acquired resistance to ICIs. For instance…

Loss of MHC class I expression in HPV-associated cervical and vulvar neoplasia: a potential mechanism of resistance to checkpoint inhibition

ME Dibbern, TN Bullock, TM Jenkins… - The American Journal …, 2020 - journals.lww.com
… to contribute to immunotherapeutic resistance in some epithelial … 1 (PD-1) checkpoint
inhibition is deployed for programmed cell … This suggests that the efficacy of checkpoint inhibitors

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

A Akinleye, Z Rasool - Journal of hematology & oncology, 2019 - Springer
… been reported to be upregulated in many other human cancers [17] by two general mechanisms,
namely innate immune resistance and adaptive immune resistance. By innate immune …

New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy

Y Wang, S Yang, L Wan, W Ling… - International …, 2023 - spandidos-publications.com
… a single therapy due to the complexity of drug resistance mechanisms. Improving the current
understanding of mechanisms limiting cancer immunotherapy may aid in the discovery of …

Resistance mechanisms of anti-PD1/PDL1 therapy in solid tumors

Q Lei, D Wang, K Sun, L Wang… - Frontiers in cell and …, 2020 - frontiersin.org
… developed acquired resistance after initial responses … mechanisms largely remain unknown.
In this review, we will focus on documented mechanisms of primary and acquired resistance

MicroRNAs as key players in melanoma cell resistance to MAPK and immune checkpoint inhibitors

ML Motti, M Minopoli, G Di Carluccio… - International journal of …, 2020 - mdpi.com
checkpoint inhibitors improve the outcomes of patients in only a subset of them and the
molecular mechanisms … In this review, we discuss the latest progress regarding mechanisms by …